New Editor-in-Chief for Gynecologic Oncology Announced
Beth Y. Karlan, M.D. new Editor-in-Chief
New York, 5 September 2007 – Elsevier, world-leading publisher of scientific, technical and medical information and the Society of Gynecologic Oncologists (SGO) are pleased to announce the appointment of Beth Y. Karlan, M.D. as the new Editor-in-Chief of Gynecologic Oncology, as of January 1 2008. Dr. Karlan succeeds David M. Gershenson M.D. who has successfully led the Journal for the past 17 years.
Dr. Karlan is the Director of the Cedars-Sinai Women’s Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute and is a world renowned expert in the field of gynecologic oncology, specifically ovarian cancer surgery, early detection, targeted therapies, and inherited cancer susceptibility. Her laboratory and translational research efforts have contributed to several innovative treatment strategies. In addition Dr. Karlan is a past-president of the SGO and is currently an Associate Editor on Gynecologic Oncology. She has also held editorial board positions with Obstetrics and Gynecology, and the Journal of Clinical Oncology.
On this new role, Dr. Karlan commented, “I'm very excited to take these leadership reins from Dr. Gershenson and welcome the opportunity to make Gynecologic Oncology the vanguard journal in our field”.
Gynecologic Oncology is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published.
As the official Journal of the Society of Gynecologic Oncologists, the Journal also brings readers the latest information emerging from the Society's task forces and publishes guidelines and position papers as they are adopted. Gynecologic Oncology is included in Index Medicus, Current Contents/Clinical Medicine, Index to Scientific Reviews, Science Citation Index, and also covered in the abstract and citation database SCOPUS
# # #
About the Society of Gynecologic Oncologists
The Society of Gynecologic Oncologists (SGO) is a national medical specialty organization of physicians who are trained in the comprehensive management of women with malignancies of the reproductive tract. Its purpose is to improve the care of women with gynecologic cancer by encouraging research, disseminating knowledge which will raise the standards of practice in the prevention and treatment of gynecologic malignancies and cooperating with other organizations interested in women’s health care, oncology and related fields. The Society’s membership is primarily comprised of gynecologic oncologists, as well as other related medical specialists such as, medical oncologists, radiation oncologists and pathologists. SGO members provide multidisciplinary cancer care including chemotherapy, radiation therapy, supportive care and surgery. More information on the SGO can be found at www.sgo.org.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
+1 212 633 3882